Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.31 USD
+0.04 (1.76%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $2.45 +0.14 (6.06%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TSHA 2.31 +0.04(1.76%)
Will TSHA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TSHA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TSHA
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
Taysha Gene Therapies, Inc. (TSHA) Just Flashed Golden Cross Signal: Do You Buy?
TSHA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Taysha Gene Therapies, Inc. (TSHA) Could Find Support Soon, Here's Why You Should Buy the Stock Now
Wall Street Analysts Believe Taysha Gene Therapies, Inc. (TSHA) Could Rally 608%: Here's is How to Trade
Other News for TSHA
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Top 10 stocks with upwards and downwards daily percentage change - Piper Sandler
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Impact and Outlook: Taysha Gene Therapies Stock Analysis
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday